Adverse event profile by folate receptor status for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

✍ Scribed by Herzog, T.J.; Kutarska, E.; Bidzinski, M.; Symanowski, J.; Nguyen, B.; Rangwala, R.; Naumann, R.W.

• Book ID: 127394286
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 98 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.469